Lv51
1238 积分 2021-04-23 加入
Fruquintinib plus paclitaxel versus placebo plus paclitaxel for gastric or gastroesophageal junction adenocarcinoma: the randomized phase 3 FRUTIGA trial
3小时前
待确认
Targeting vascular endothelial growth factor and angiogenesis for the treatment of colorectal cancer
2个月前
已完结
Combined anti-PD-1, HDAC inhibitor and anti-VEGF for MSS/pMMR colorectal cancer: a randomized phase 2 trial
3个月前
已完结
Efficacy and safety of weekly paclitaxel with or without ramucirumab as second-line therapy for the treatment of advanced gastric or gastroesophageal junction adenocarcinoma (RAINBOW-Asia): a randomised, multicentre, double-blind, phase 3 trial
5个月前
已完结
Gastric cancer
5个月前
已完结
503LBA LBA Orals: Results from CA240-0007, a phase 1/2 multiple expansion cohort study of BMS-986504 in patients (pts) with advanced solid tumors with homozygous MTAP deletion (MTAP-del)
5个月前
已完结
Comparison between MGI and Illumina sequencing platforms for whole genome sequencing
6个月前
已完结
Advances in the diagnosis and prognosis of minimal residual lesions of breast cancer
6个月前
已完结
Oncolytic virus VG161 in refractory hepatocellular carcinoma
7个月前
已完结
The prognostic value of tumor-informed minimal residual disease detection using circulating tumor DNA in first-line treatment of ovarian cancer
7个月前
已完结
皖公网安备34019202002308
